THE MIZEUR GROUP, LLC for CLENE NANOMEDICINE
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Navigating policy issues that surround FDA approval of company's treatments for neurodegenerative diseases (like ALS, MS, and Parkinson's) through restoration and protection of nueronal health and function, including seeking regulatory flexibility through Accelerated Approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER R MIZEUR New | — |
Medical/Disease Research/Clinical Labs MED
Navigating policy issues that surround FDA approval of company's treatments for neurodegenerative diseases (like ALS, MS, and Parkinson's) through restoration and protection of nueronal health and function, including seeking regulatory flexibility through Accelerated Approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER R MIZEUR New | — |
Budget/Appropriations BUD
Navigating policy issues that surround FDA approval of company's treatments for neurodegenerative diseases (like ALS, MS, and Parkinson's) through restoration and protection of nueronal health and function, including seeking regulatory flexibility through Accelerated Approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER R MIZEUR New | — |
Medicare/Medicaid MMM
Navigating policy issues that surround FDA approval of company's treatments for neurodegenerative diseases (like ALS, MS, and Parkinson's) through restoration and protection of nueronal health and function, including seeking regulatory flexibility through Accelerated Approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEATHER R MIZEUR New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.